Dynatronics Corporation (DYNT)
USD 0.11
(1.92%)
USD 0.11
(1.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 6.2 Million USD | 21.75% |
| 2023 | 5.09 Million USD | 62.4% |
| 2022 | 3.13 Million USD | 368.31% |
| 2021 | -1.16 Million USD | 10.26% |
| 2020 | -1.3 Million USD | -113.18% |
| 2019 | 9.88 Million USD | 19.76% |
| 2018 | 8.25 Million USD | 42.05% |
| 2017 | 5.81 Million USD | 82.26% |
| 2016 | 3.18 Million USD | 33.15% |
| 2015 | 2.39 Million USD | -49.53% |
| 2014 | 4.74 Million USD | -6.55% |
| 2013 | 5.07 Million USD | -8.17% |
| 2012 | 5.53 Million USD | 15.09% |
| 2011 | 4.8 Million USD | -10.53% |
| 2010 | 5.37 Million USD | -29.94% |
| 2009 | 7.66 Million USD | -13.6% |
| 2008 | 8.87 Million USD | 258.88% |
| 2007 | 2.47 Million USD | 1.67% |
| 2006 | 2.43 Million USD | 81.05% |
| 2005 | 1.34 Million USD | -51.9% |
| 2004 | 2.79 Million USD | -4.71% |
| 2003 | 2.93 Million USD | -8.84% |
| 2002 | 3.21 Million USD | -31.4% |
| 2001 | 4.68 Million USD | 17.9% |
| 2000 | 3.97 Million USD | -15.43% |
| 1999 | 4.7 Million USD | 34.29% |
| 1998 | 3.5 Million USD | 52.17% |
| 1997 | 2.3 Million USD | -11.54% |
| 1996 | 2.6 Million USD | 85.71% |
| 1995 | 1.4 Million USD | -6.67% |
| 1994 | 1.5 Million USD | 150.0% |
| 1993 | 600 Thousand USD | 166.67% |
| 1992 | -900 Thousand USD | -28.57% |
| 1991 | -700 Thousand USD | -600.0% |
| 1990 | -100 Thousand USD | 85.71% |
| 1989 | -700 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 6.2 Million USD | -3.38% |
| 2024 Q1 | 1.21 Million USD | -76.12% |
| 2024 Q3 | 6.42 Million USD | -1.32% |
| 2024 Q2 | 6.5 Million USD | 434.68% |
| 2023 FY | 5.09 Million USD | 62.4% |
| 2023 Q1 | 2.71 Million USD | -17.58% |
| 2023 Q4 | 5.09 Million USD | -3.17% |
| 2023 Q3 | 5.26 Million USD | 7.59% |
| 2023 Q2 | 4.89 Million USD | 80.47% |
| 2022 Q1 | -562.28 Thousand USD | 51.92% |
| 2022 Q3 | 1.83 Million USD | 74.96% |
| 2022 Q2 | 1.04 Million USD | 286.45% |
| 2022 FY | 3.13 Million USD | 368.31% |
| 2022 Q4 | 3.28 Million USD | 79.28% |
| 2021 Q2 | 5.67 Million USD | -22.79% |
| 2021 FY | -1.16 Million USD | 10.26% |
| 2021 Q1 | 7.34 Million USD | 663.8% |
| 2021 Q3 | 4.37 Million USD | -22.95% |
| 2021 Q4 | -1.16 Million USD | -126.76% |
| 2020 Q2 | 10.86 Million USD | -6.49% |
| 2020 Q1 | 11.62 Million USD | 17.56% |
| 2020 Q3 | 11.14 Million USD | 2.55% |
| 2020 Q4 | -1.3 Million USD | -111.69% |
| 2020 FY | -1.3 Million USD | -113.18% |
| 2019 Q3 | 7.99 Million USD | -1.22% |
| 2019 Q4 | 9.88 Million USD | 23.68% |
| 2019 FY | 9.88 Million USD | 19.76% |
| 2019 Q1 | 8.16 Million USD | -1.15% |
| 2019 Q2 | 8.09 Million USD | -0.82% |
| 2018 Q4 | 8.25 Million USD | -4.98% |
| 2018 FY | 8.25 Million USD | 42.05% |
| 2018 Q1 | 5.36 Million USD | -7.66% |
| 2018 Q3 | 8.68 Million USD | 27.37% |
| 2018 Q2 | 6.82 Million USD | 27.1% |
| 2017 Q4 | 5.81 Million USD | 83.73% |
| 2017 FY | 5.81 Million USD | 82.26% |
| 2017 Q1 | 3.18 Million USD | 0.01% |
| 2017 Q2 | 2.31 Million USD | -27.42% |
| 2017 Q3 | 3.16 Million USD | 36.66% |
| 2016 Q4 | 3.18 Million USD | 1.11% |
| 2016 FY | 3.18 Million USD | 33.15% |
| 2016 Q3 | 3.15 Million USD | 10.1% |
| 2016 Q2 | 2.86 Million USD | -3.73% |
| 2016 Q1 | 2.97 Million USD | 24.25% |
| 2015 Q3 | 6.05 Million USD | 2.64% |
| 2015 Q1 | 5.13 Million USD | 8.24% |
| 2015 Q2 | 5.9 Million USD | 14.9% |
| 2015 FY | 2.39 Million USD | -49.53% |
| 2015 Q4 | 2.39 Million USD | -60.46% |
| 2014 Q1 | 5.19 Million USD | 2.33% |
| 2014 Q4 | 4.74 Million USD | -8.36% |
| 2014 Q2 | 4.97 Million USD | -4.21% |
| 2014 Q3 | 5.17 Million USD | 4.02% |
| 2014 FY | 4.74 Million USD | -6.55% |
| 2013 Q2 | 5.4 Million USD | -3.6% |
| 2013 Q4 | 5.07 Million USD | -10.38% |
| 2013 Q3 | 5.66 Million USD | 4.93% |
| 2013 FY | 5.07 Million USD | -8.17% |
| 2013 Q1 | 5.6 Million USD | 1.29% |
| 2012 Q1 | 5.39 Million USD | 12.2% |
| 2012 Q3 | 5.91 Million USD | 14.48% |
| 2012 FY | 5.53 Million USD | 15.09% |
| 2012 Q4 | 5.53 Million USD | -6.52% |
| 2012 Q2 | 5.16 Million USD | -4.14% |
| 2011 FY | 4.8 Million USD | -10.53% |
| 2011 Q4 | 4.8 Million USD | -5.98% |
| 2011 Q3 | 5.11 Million USD | 2.13% |
| 2011 Q2 | 5 Million USD | -7.17% |
| 2011 Q1 | 5.39 Million USD | 0.37% |
| 2010 Q1 | 7.76 Million USD | 1.34% |
| 2010 FY | 5.37 Million USD | -29.94% |
| 2010 Q4 | 5.37 Million USD | -19.83% |
| 2010 Q3 | 6.7 Million USD | -4.82% |
| 2010 Q2 | 7.03 Million USD | -9.4% |
| 2009 FY | 7.66 Million USD | -13.6% |
| 2009 Q1 | 8.62 Million USD | -2.84% |
| 2009 Q4 | 7.66 Million USD | -10.44% |
| 2009 Q2 | 9.16 Million USD | 6.35% |
| 2009 Q3 | 8.55 Million USD | -6.65% |
| 2008 Q2 | 8.84 Million USD | 25.07% |
| 2008 Q3 | 8.92 Million USD | 0.85% |
| 2008 FY | 8.87 Million USD | 258.88% |
| 2008 Q4 | 8.87 Million USD | -0.53% |
| 2008 Q1 | 7.07 Million USD | 186.03% |
| 2007 Q1 | 2.84 Million USD | 16.79% |
| 2007 FY | 2.47 Million USD | 1.67% |
| 2007 Q4 | 2.47 Million USD | -24.74% |
| 2007 Q3 | 3.28 Million USD | 21.56% |
| 2007 Q2 | 2.7 Million USD | -4.85% |
| 2006 FY | 2.43 Million USD | 81.05% |
| 2006 Q1 | 1.95 Million USD | 45.63% |
| 2006 Q2 | 1.91 Million USD | -2.14% |
| 2006 Q3 | 3.06 Million USD | 60.32% |
| 2006 Q4 | 2.43 Million USD | -20.76% |
| 2005 Q4 | 1.34 Million USD | -24.37% |
| 2005 FY | 1.34 Million USD | -51.9% |
| 2005 Q1 | 2.5 Million USD | -10.32% |
| 2005 Q2 | 2.23 Million USD | -10.8% |
| 2005 Q3 | 1.77 Million USD | -20.49% |
| 2004 Q3 | 3.21 Million USD | 9.63% |
| 2004 Q2 | 2.92 Million USD | -13.8% |
| 2004 Q1 | 3.39 Million USD | 15.98% |
| 2004 Q4 | 2.79 Million USD | -13.05% |
| 2004 FY | 2.79 Million USD | -4.71% |
| 2003 FY | 2.93 Million USD | -8.84% |
| 2003 Q1 | 3.16 Million USD | -1.56% |
| 2003 Q3 | 2.99 Million USD | 4.73% |
| 2003 Q2 | 2.85 Million USD | -9.75% |
| 2003 Q4 | 2.93 Million USD | -2.03% |
| 2002 Q2 | 4.47 Million USD | -3.1% |
| 2002 FY | 3.21 Million USD | -31.4% |
| 2002 Q4 | 3.21 Million USD | -20.44% |
| 2002 Q3 | 4.04 Million USD | -9.75% |
| 2002 Q1 | 4.62 Million USD | -1.4% |
| 2001 Q3 | 3.9 Million USD | 14.68% |
| 2001 FY | 4.68 Million USD | 17.9% |
| 2001 Q1 | 3.58 Million USD | -9.84% |
| 2001 Q2 | 3.4 Million USD | -4.92% |
| 2001 Q4 | 4.68 Million USD | 19.92% |
| 2000 FY | 3.97 Million USD | -15.43% |
| 2000 Q2 | 4.9 Million USD | -5.77% |
| 2000 Q3 | 4.5 Million USD | -8.06% |
| 2000 Q4 | 3.97 Million USD | -11.77% |
| 2000 Q1 | 5.2 Million USD | 10.64% |
| 1999 Q1 | 4.7 Million USD | 34.29% |
| 1999 Q3 | 5.2 Million USD | 0.0% |
| 1999 Q4 | 4.7 Million USD | -9.62% |
| 1999 Q2 | 5.2 Million USD | 10.64% |
| 1999 FY | 4.7 Million USD | 34.29% |
| 1998 Q2 | 2.9 Million USD | 26.09% |
| 1998 Q3 | 3.2 Million USD | 10.34% |
| 1998 Q4 | 3.5 Million USD | 9.38% |
| 1998 FY | 3.5 Million USD | 52.17% |
| 1998 Q1 | 2.3 Million USD | 0.0% |
| 1997 Q2 | 2.6 Million USD | -6.14% |
| 1997 Q4 | 2.3 Million USD | 0.0% |
| 1997 FY | 2.3 Million USD | -11.54% |
| 1997 Q1 | 2.77 Million USD | 6.54% |
| 1997 Q3 | 2.3 Million USD | -11.54% |
| 1996 Q3 | 1 Million USD | -28.57% |
| 1996 FY | 2.6 Million USD | 85.71% |
| 1996 Q1 | 1.6 Million USD | 14.29% |
| 1996 Q2 | 1.4 Million USD | -12.5% |
| 1996 Q4 | 2.6 Million USD | 160.0% |
| 1995 Q1 | 2.1 Million USD | 40.0% |
| 1995 FY | 1.4 Million USD | -6.67% |
| 1995 Q4 | 1.4 Million USD | -26.32% |
| 1995 Q3 | 1.9 Million USD | -5.0% |
| 1995 Q2 | 2 Million USD | -4.76% |
| 1994 Q3 | 2 Million USD | 17.65% |
| 1994 Q1 | 1.6 Million USD | 166.67% |
| 1994 Q2 | 1.7 Million USD | 6.25% |
| 1994 Q4 | 1.5 Million USD | -25.0% |
| 1994 FY | 1.5 Million USD | 150.0% |
| 1993 FY | 600 Thousand USD | 166.67% |
| 1993 Q3 | 800 Thousand USD | 300.0% |
| 1993 Q1 | -500 Thousand USD | 44.44% |
| 1993 Q2 | 200 Thousand USD | 140.0% |
| 1993 Q4 | 600 Thousand USD | -25.0% |
| 1992 Q4 | -900 Thousand USD | -50.0% |
| 1992 Q2 | -600 Thousand USD | 0.0% |
| 1992 FY | -900 Thousand USD | -28.57% |
| 1992 Q1 | -600 Thousand USD | 14.29% |
| 1992 Q3 | -600 Thousand USD | 0.0% |
| 1991 FY | -700 Thousand USD | -600.0% |
| 1991 Q2 | -100 Thousand USD | 0.0% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q3 | -200 Thousand USD | -100.0% |
| 1991 Q4 | -700 Thousand USD | -250.0% |
| 1990 Q3 | -200 Thousand USD | 0.0% |
| 1990 FY | -100 Thousand USD | 85.71% |
| 1990 Q4 | -100 Thousand USD | 50.0% |
| 1989 Q4 | -700 Thousand USD | 0.0% |
| 1989 FY | -700 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 77.092% |
| BrainsWay Ltd. | -10.32 Million USD | 160.117% |
| Cerus Corporation | 84.35 Million USD | 92.645% |
| Envoy Medical, Inc. | -3.81 Million USD | 262.665% |
| electroCore, Inc. | -9.95 Million USD | 162.321% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 221.054% |
| IceCure Medical Ltd | -9.93 Million USD | 162.453% |
| Inogen, Inc. | -103.56 Million USD | 105.99% |
| OrthoPediatrics Corp. | -9.26 Million USD | 166.948% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 270.394% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 147.37% |
| MaxCyte, Inc. | -27.76 Million USD | 122.346% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 220.746% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1177.525% |
| Orthofix Medical Inc. | 96.44 Million USD | 93.567% |
| PAVmed Inc | 29.08 Million USD | 78.67% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 136.626% |
| RxSight, Inc. | -6.68 Million USD | 192.875% |
| Sight Sciences, Inc. | -102.71 Million USD | 106.04% |
| SI-BONE, Inc. | 5.72 Million USD | -8.443% |
| TELA Bio, Inc. | -3.94 Million USD | 257.104% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 89.177% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -1662.509% |
| Acutus Medical, Inc. | 12.27 Million USD | 49.474% |
| Talis Biomedical Corporation | -57.06 Million USD | 110.872% |
| Spectral AI, Inc. | -3.5 Million USD | 277.207% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 112.918% |
| CVRx, Inc. | -59.95 Million USD | 110.348% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -212.68% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -385.587% |
| Bioventus Inc. | 372.51 Million USD | 98.335% |
| Venus Concept Inc. | 74.3 Million USD | 91.65% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 160.931% |
| LivaNova PLC | 62.53 Million USD | 90.079% |
| 908 Devices Inc. | -115.09 Million USD | 105.39% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 98.066% |
| Nemaura Medical Inc. | 9.92 Million USD | 37.491% |
| NeuroPace, Inc. | 54.33 Million USD | 88.582% |
| LENSAR, Inc. | -18.31 Million USD | 133.88% |
| Apyx Medical Corporation | -5.15 Million USD | 220.443% |
| Cutera, Inc. | 288.3 Million USD | 97.848% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 17.445% |
| BioSig Technologies, Inc. | 262 Thousand USD | -2267.952% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 114.155% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 167.442% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.559% |
| Axonics, Inc. | -77.19 Million USD | 108.037% |
| Outset Medical, Inc. | 67.67 Million USD | 90.833% |
| IRIDEX Corporation | -4.28 Million USD | 244.684% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 103.485% |
| IRadimed Corporation | -47.71 Million USD | 113.001% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 305.024% |
| INVO Bioscience, Inc. | 8.45 Million USD | 26.589% |
| Telesis Bio, Inc. | 32.63 Million USD | 80.99% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 347.95% |
| Varex Imaging Corporation | 316.9 Million USD | 98.042% |
| Quipt Home Medical Corp. | 81.73 Million USD | 92.41% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 323.006% |
| Pulmonx Corporation | -42.36 Million USD | 114.646% |
| Modular Medical, Inc. | -8.04 Million USD | 177.145% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 244.381% |
| Semler Scientific, Inc. | -57.13 Million USD | 110.86% |
| InMode Ltd. | -135.39 Million USD | 104.582% |
| Bruker Corporation | 891.3 Million USD | 99.304% |
| Cytosorbents Corporation | 4.18 Million USD | -48.35% |
| DexCom, Inc. | 2.02 Billion USD | 99.694% |
| Align Technology, Inc. | -840.47 Million USD | 100.738% |
| Viveve Medical, Inc. | -13.81 Million USD | 144.914% |
| ZimVie Inc. | 450.41 Million USD | 98.623% |
| Movano Inc. | -5.86 Million USD | 205.763% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 104.614% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1177.525% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -212.68% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 98.261% |
| Profound Medical Corp. | -18.17 Million USD | 134.128% |
| Insulet Corporation | 798.1 Million USD | 99.223% |
| enVVeno Medical Corporation | -2.21 Million USD | 379.713% |
| Surmodics, Inc. | -12.01 Million USD | 151.64% |
| iCAD, Inc. | -21.2 Million USD | 129.252% |
| Nuwellis, Inc. | -2.81 Million USD | 320.079% |
| Biotricity, Inc. | 23.09 Million USD | 73.134% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 93.375% |
| Aethlon Medical, Inc. | -4.5 Million USD | 237.816% |
| InspireMD, Inc. | -8.04 Million USD | 177.117% |
| PAVmed Inc. | 29.08 Million USD | 78.67% |
| BIOLASE, Inc. | 11.34 Million USD | 45.31% |
| Beyond Air, Inc. | 6.22 Million USD | 0.401% |
| FONAR Corporation | -14.66 Million USD | 142.304% |
| AxoGen, Inc. | 32.26 Million USD | 80.772% |
| Vivani Medical, Inc. | 42 Thousand USD | -14671.507% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 158.21% |
| Inari Medical, Inc. | -7.16 Million USD | 186.636% |
| UFP Technologies, Inc. | 40.77 Million USD | 84.784% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -102.176% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 230.028% |
| Tenon Medical, Inc. | -1.25 Million USD | 594.345% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 181.568% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 152.02% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.72% |
| Sintx Technologies, Inc. | 905 Thousand USD | -585.529% |
| NanoVibronix, Inc. | -3.27 Million USD | 289.263% |
| Quanterix Corporation | -132.95 Million USD | 104.666% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 323.006% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 127.74% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.177% |
| TransMedics Group, Inc. | 121.13 Million USD | 94.878% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 123.698% |
| NeuroMetrix, Inc. | -1.49 Million USD | 516.079% |
| Hyperfine, Inc. | -75.61 Million USD | 108.204% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 95.923% |
| Biomerica, Inc. | -3.38 Million USD | 283.28% |
| Bone Biologics Corporation | -3.02 Million USD | 304.986% |
| AVITA Medical, Inc. | -26.23 Million USD | 123.651% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 437.467% |
| Silk Road Medical, Inc | 64.42 Million USD | 90.37% |